Th1 subtype of CD4+T cells directly destroy tumor cells by secreting IFN-γ and TNF, whereas Th2 subtype secretes anti-inflammatory mediators such as IL4, which suppress immunity and support tumor growth. Here, CD4 is linked to neoplasm.